Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumors may potentially be more susceptible to macrophage-based therapies.

Pancreatic cancer patients may benefit from future precision treatments as a new study shows how some tumours may potentially be more susceptible to ...

Modern medicine is helping clinicians tailor cancer treatments for individuals and Birmingham researchers are at the ...

Carey, a sustainable tourism consultant, is heading to the House of Commons on February 26 and to the Scottish Parliament on ...

High-dose intravenous vitamin C combined with standard chemotherapy significantly extends survival in patients with metastatic pancreatic cancer. Learn more.

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...

Medical announced positive interim data from multiple clinical trials, including safety and feasibility studies treating ...

Adding lanreotide to everolimus significantly prolonged progression-free survival compared with everolimus alone in patients ...

SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...